DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- www.247marketnews.com -- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long sought by researchers for its unusual combination of strength and elasticity. Kraig Biocraft Laboratories (OTCQB: KBLB) deployed one million genetically engineered silkworm eggs across multiple production facilities in Vietnam as part of a Spring scale-up effort that could eventually produce aroun ...

DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- www.247marketnews.com -- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long sought by researchers for its unusual combination of strength and elasticity. Kraig Biocraft Laboratories (OTCQB: KBLB) deployed one million genetically engineered silkworm eggs across multiple production facilities in Vietnam as part of a Spring scale-up effort that could eventually produce aroun ...

Core Insights - Kraig Biocraft Laboratories (OTCQB: KBLB) is featured on the cover of the March issue of National Geographic, highlighting a significant scientific breakthrough in the production of spider silk, a material known for its exceptional strength and toughness [1][8]. Company Overview - Kraig Biocraft Laboratories is a biotechnology company focused on developing and commercializing spider silk-based fiber technologies, utilizing genetically engineered silkworms to produce high-performance, cost-effective, and scalable spider silk materials for various applications [10]. Scientific Breakthrough - The article titled "Unlocking Nature's Miracle" discusses the global effort to manufacture spider silk, emphasizing the transition of spider silk from a laboratory curiosity to a scalable biomaterial [1][3]. - Spider silk's extraordinary properties are attributed to specialized proteins called spidroins, which form fibers with unmatched tensile strength, elasticity, and toughness [4]. Production Method - The company has developed genetically engineered silkworm strains that can produce recombinant spider silk proteins, leveraging the silkworm's natural spinning system to create a viable production method [5][6]. - This production method is positioned alongside other international efforts, including fermentation-driven systems, providing a comprehensive overview of the advancements in the field [6]. Market Relevance - The March issue of National Geographic serves as a significant resource for readers interested in advanced materials, synthetic biology, and sustainable fibers, marking a growing mainstream interest in the field of recombinant biomaterials [7][8].

If you alive today, you are already a user of genetic engineering. Not in a laboratory, not in a future, but in your everyday life. Most people imagine genetic engineering as touching distance, designers, babies, artificial humans, just a science fiction.But the truth is much wider and much closer. When people hear words genetic engineering, they think of control dangerous experiments. But you know what.They rarely think of survival. The insulin used by millions of people with diabetes is produced attention ...

Core Insights - Kraig Biocraft Laboratories, Inc. is launching an ambitious genetic engineering initiative aimed at enhancing the strength and elasticity of recombinant spider silk beyond current capabilities [1][4] - The company has completed the construction phase of advanced spider silk gene constructs, marking a significant milestone in its research and development efforts [2][3] - This initiative is the largest and most complex silkworm gene-engineering project globally, building on years of proprietary research to enhance performance and scalability [3][4] Company Developments - The new genetic engineering program is expected to drive innovation in the company's production pipeline, leading to improved fiber performance and product diversification [4][5] - Kraig Labs aims to solidify its leadership position in commercial-scale spider silk manufacturing through this initiative [4][5] - The company emphasizes its long-term commitment to innovation while advancing the commercialization of existing products [5]

Market Overview - The global agriculture biotechnology market was valued at USD 84.39 billion in 2024 and is projected to reach USD 144.25 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.4% during 2025–2030 [1][3] - Market growth is driven by the rising adoption of genetically modified (GM) crops, microbial biofertilizers, animal vaccines, and sustainable biotechnology-based agricultural inputs aimed at improving productivity and resilience [1][5] Regional Insights - North America currently leads the market, supported by a strong regulatory framework, continuous technological innovation, and the presence of major industry players such as Bayer, Corteva, BASF, and Novonesis [3][12] - Asia Pacific is emerging as the fastest-growing region, driven by rapid biotechnology adoption in countries including India, China, and Australia, along with favorable government initiatives promoting bio-based agriculture [3][12] Key Drivers - The agriculture biotechnology market is primarily driven by the increasing global demand for sustainable and efficient food production systems due to rapid population growth, declining arable land availability, and changing climatic conditions [5][6] - Significant technological advancements in genetic engineering, genome editing (CRISPR-Cas9), and microbial biotechnology are enabling the development of stress-tolerant crops, biofertilizers, and biopesticides [6][9] Market Segmentation - Plant biotechnology and microbial biotechnology segments are expected to account for a significant share of the agriculture biotechnology market, with plant biotechnology remaining dominant due to widespread adoption of GM crops [8][9] - The animal biotechnology segment is expected to register the fastest growth during the forecast period, supported by increasing focus on livestock health, productivity improvement, and sustainable protein production [10][11] Future Outlook - The agriculture biotechnology market is poised for robust growth in the next five years, driven by the convergence of biology, data, and sustainability [15][17] - Key predictions include continued growth in microbial biofertilizers and biostimulants, expansion of gene-editing technologies across commercial crops, and greater adoption of AI-enabled precision agriculture [17]

In Lambert High School's lab, Shaun Lee and his classmates are teenage genetic engineers manipulating the building blocks of life. >> And what we're going to do is we're going to move each of these samples into these mixes. And these mixes have everything we need in order to amplify our DNA.>> It's It's currently amplifying. >> Yes. All right.And we'll have to do this three more times for our different samples. So you would kind of swipe across. >> We went to check out the IGM team's project for the big Par ...

Genetically engineered babies are banned. Tech billionaires are trying to make one anyway. https://t.co/fLk4n5gt6v ...

Core Insights - Kraig Biocraft Laboratories, Inc. has significantly increased the production throughput of its recombinant spider silk production platform, marking a major advancement in spider silk technology [1][6]. Company Developments - The increase in production is attributed to the successful selective breeding of parental strains for hybrid silkworms, which form the basis of the recombinant spider silk production system [2][3]. - The first successful hybrid, BAM-1, demonstrated hybrid vigor, leading to increased cocoon shell weight and robustness, which are critical for silk output [2][4]. - The new advanced hybrid, BAM-1 Alpha, has shown a measurable hybrid vigor increase of 22%, representing over a 245% improvement compared to the original BAM-1 [4][5]. Production and Commercialization - The BAM-1 Alpha hybrid is expected to be the primary production strain moving forward, producing larger cocoons and more silk, which will lower production costs [5][6]. - Kraig Labs plans to leverage its multi-facility production infrastructure to integrate BAM-1 Alpha into ongoing manufacturing, supporting its vision of delivering high-performance spider silk fibers for various applications [6][7]. Industry Position - Kraig Labs continues to lead in spider silk research and development, focusing on large-scale commercialization of spider silk technologies [5][7]. - The company's advancements in spider silk technology have significant implications for the global textile industry, with potential applications in performance textiles, defense, medical, and industrial markets [6][10].

Core Insights - Kraig Biocraft Laboratories has achieved a significant milestone in biotechnology by successfully mass-producing spider silk using genetically engineered silkworms, addressing a long-standing challenge in the field [1][4][5] Company Overview - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) focuses on the development and commercialization of spider silk-based fiber technologies, utilizing a proprietary silkworm-based genetic engineering platform to produce high-performance, cost-effective, and scalable spider silk materials [8] Technological Breakthrough - The company’s genetically engineered silkworms serve as a factory for spider silk production, enabling a scalable and sustainable supply chain that transitions spider silk from laboratory research to practical applications [4][5] Market Potential - The global spider silk market is projected to grow significantly, with forecasts estimating it will reach between $1.3 billion and $1.5 billion by 2035, reflecting a compound annual growth rate (CAGR) of over 30% [6] - This growth is expected to be driven by demand in various sectors, including biomedical applications (sutures, scaffolds, implants), textiles, military uses, and sustainable materials for aerospace and automotive industries [6] Unique Properties of Spider Silk - Spider silk is recognized for its exceptional mechanical properties, including a superior tensile strength-to-weight ratio, outperforming materials like Kevlar and steel [6][7] - Its biocompatibility and biodegradability make it an attractive option for various applications, particularly in biomedical and sustainable material sectors [2][6] Applications and Opportunities - Potential applications for spider silk include stronger and lighter wearables, biodegradable sutures, next-generation body armor, sustainable textiles, and biomimetic actuators in robotics [9]